Jorge Adeva

8PUBLICATIONS
103CO-AUTHORS
Molecular targetsCancer geneticsGastroenterology and hepatologyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2026
Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

|May 28, 2026
Current patterns of next-generation sequencing testing in biliary tract cancer patients in Spain.

|Sep 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

James J Harding, Do-Youn Oh, Teresa Macarulla Mercade

|Aug 09, 2025
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry.

Carlos López-López, Eva Martínez de Castro, Ana Fernández Montes

|Jun 17, 2025
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC-D Index.

Mara Persano, Margherita Rimini, Francesca Salani

|Aug 07, 2021
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.

Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi

Pageof 2